{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T02:16:51Z","timestamp":1772936211607,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012964","name":"Minist\u00e8re de l\u2019Enseignement Sup\u00e9rieur et de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012964","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.prp.2023.154484","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T20:07:20Z","timestamp":1682453240000},"page":"154484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Epstein-Barr virus in breast carcinoma and in triple negative cases impact on clinical outcomes"],"prefix":"10.1016","volume":"245","author":[{"given":"Saoussen","family":"Mekrazi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imen","family":"Kallel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhouha","family":"Jamai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariem","family":"Yengui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelmajid","family":"Khabir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radhouane","family":"Gdoura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2023.154484_bib1","article-title":"Breast cancer: a public health issue that is also subject of social construction","volume":"5","author":"Santamar\u00eda-Ulloa","year":"2020","journal-title":"Nov. Approaches Cancer Study"},{"key":"10.1016\/j.prp.2023.154484_bib2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s12282-018-00941-4","article-title":"Breast cancer incidence, mortality and mortality-to-incidence ratio (MIR) are associated with human development, 1990-2016: evidence from Global Burden of Disease Study 2016","volume":"26","author":"Sharma","year":"2019","journal-title":"Breast Cancer"},{"key":"10.1016\/j.prp.2023.154484_bib3","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: A Cancer J. Clin."},{"key":"10.1016\/j.prp.2023.154484_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268035","article-title":"Breast cancer incidence and predictions (Monastir, Tunisia: 2002-2030): A registry-based study","volume":"17","author":"Zemni","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2023.154484_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1750-9378-9-37","article-title":"Detection of MMTV-Like sequences in Moroccan breast cancer cases","volume":"9","author":"Slaoui","year":"2014","journal-title":"Infect. Agents Cancer"},{"key":"10.1016\/j.prp.2023.154484_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2018.00001","article-title":"Oncogenic viruses and breast cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein-Barr Virus (EBV)","volume":"8","author":"Lawson","year":"2018","journal-title":"Front Oncol."},{"key":"10.1016\/j.prp.2023.154484_bib7","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3390\/cancers2020752","article-title":"Viruses and breast cancer","volume":"2","author":"Lawson","year":"2010","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2023.154484_bib8","doi-asserted-by":"crossref","first-page":"8337","DOI":"10.1007\/s13277-015-4562-0","article-title":"Genetic variants in EBV reactivation-related genes and the risk and survival of breast cancer","volume":"37","author":"Zhang","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.prp.2023.154484_bib9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3390\/cancers13040819","article-title":"Is EBV associated with breast cancer in specific geographic locations?","volume":"13","author":"Sinclair","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2023.154484_bib10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1158\/1078-0432.CCR-0670-3","article-title":"Epstein-Barr virus and cancer","volume":"10","author":"Thompson","year":"2004","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.prp.2023.154484_bib11","doi-asserted-by":"crossref","first-page":"745","DOI":"10.5114\/aoms.2013.37274","article-title":"Association of Epstein-Barr virus infection and breast carcinoma","volume":"9","author":"Khabaz","year":"2013","journal-title":"Arch. Med Sci."},{"key":"10.1016\/j.prp.2023.154484_bib12","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/sj.bjc.6606048","article-title":"Epstein-Barr virus as a marker of biological aggressiveness in breast cancer","volume":"104","author":"Mazouni","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2023.154484_bib13","first-page":"188","article-title":"Incidence of HPVs, EBV, and MMTV-Like Virus in Breast Cancer in Qatar","volume":"65","author":"Gupta","year":"2022","journal-title":"INT"},{"key":"10.1016\/j.prp.2023.154484_bib14","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.2217\/fon-2019-0232","article-title":"Epstein-Barr virus and risk of breast cancer: a systematic review and meta-analysis","volume":"15","author":"Farahmand","year":"2019","journal-title":"Future Oncol."},{"key":"10.1016\/j.prp.2023.154484_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13027-017-0173-2","article-title":"Association of Epstein - Barr virus and breast cancer in Eritrea","volume":"12","author":"Fessahaye","year":"2017","journal-title":"Infect. Agents Cancer"},{"key":"10.1016\/j.prp.2023.154484_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11010-008-9755-z","article-title":"Epstein-Barr virus induces an oxidative stress during the early stages of infection in B lymphocytes, epithelial, and lymphoblastoid cell lines","volume":"313","author":"Lassoued","year":"2008","journal-title":"Mol. Cell Biochem"},{"key":"10.1016\/j.prp.2023.154484_bib17","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1128\/JVI.74.6.2612-2619.2000","article-title":"Infection of primary human monocytes by Epstein-Barr virus","volume":"74","author":"Savard","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.prp.2023.154484_bib18","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.5858\/arpa.2018-0902-SA","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: american society of clinical oncology\/college of american pathologists clinical practice guideline focused update","volume":"142","author":"Wolff","year":"2018","journal-title":"Arch. Pathol. Lab Med"},{"key":"10.1016\/j.prp.2023.154484_bib19","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1186\/bcr2128","article-title":"Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer","volume":"10","author":"Tamimi","year":"2008","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.prp.2023.154484_bib20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00795-017-0170-y","article-title":"Significance of evaluating tumor-infiltrating lymphocytes (TILs) and programmed cell death-ligand 1 (PD-L1) expression in breast cancer","volume":"50","author":"Kurozumi","year":"2017","journal-title":"Med Mol. Morphol."},{"key":"10.1016\/j.prp.2023.154484_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12885-019-5286-0","article-title":"Human papilloma virus and breast cancer: the role of inflammation and viral expressed proteins","volume":"19","author":"Khodabandehlou","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2023.154484_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-9378-8-32","article-title":"Role of viruses in the development of breast cancer","volume":"8","author":"Alibek","year":"2013","journal-title":"Infect. Agent Cancer"},{"key":"10.1016\/j.prp.2023.154484_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008180","article-title":"Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women","volume":"4","author":"Joshi","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2023.154484_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118989","article-title":"Cytomegalovirus and Epstein-Barr Virus in Breast Cancer","volume":"10","author":"Richardson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2023.154484_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048788","article-title":"Epstein-Barr virus, human papillomavirus and mouse mammary tumour virus as multiple viruses in breast cancer","volume":"7","author":"Glenn","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2023.154484_bib26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/tbj.12828","article-title":"Evidence for the association of Epstein-Barr Virus in breast cancer in Indian patients using in-situ hybridization technique","volume":"24","author":"Pai","year":"2018","journal-title":"Breast J."},{"key":"10.1016\/j.prp.2023.154484_bib27","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/bcr561","article-title":"Lack of evidence for an association of Epstein-Barr virus infection with breast carcinoma","volume":"5","author":"Herrmann","year":"2003","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.prp.2023.154484_bib28","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1158\/1055-9965.688.13.5","article-title":"Epstein-Barr virus and breast cancer: state of the evidence for viral carcinogenesis","volume":"13","author":"Glaser","year":"2004","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.prp.2023.154484_bib29","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12935-021-02009-4","article-title":"High-risk human papillomaviruses and Epstein-Barr virus in breast cancer in Lebanese women and their association with tumor grade: a molecular and tissue microarray study","volume":"21","author":"Nagi","year":"2021","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.prp.2023.154484_bib30","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.meegid.2017.07.010","article-title":"Prevalence of EBV, HPV and MMTV in Pakistani breast cancer patients: A possible etiological role of viruses in breast cancer","volume":"54","author":"Naushad","year":"2017","journal-title":"Infect. Genet Evol."},{"key":"10.1016\/j.prp.2023.154484_bib31","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1080\/21645515.2020.1802977","article-title":"The co-presence of high-risk human papillomaviruses and Epstein-Barr virus is linked with tumor grade and stage in Qatari women with breast cancer","volume":"17","author":"Gupta","year":"2021","journal-title":"Hum. Vaccin Immunother."},{"key":"10.1016\/j.prp.2023.154484_bib32","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.2147\/IDR.S313219","article-title":"Presence of HPV, EBV and HMTv viruses among egyptian breast cancer women: molecular detection and clinical relevance","volume":"14","author":"Metwally","year":"2021","journal-title":"Infect. Drug Resist"},{"key":"10.1016\/j.prp.2023.154484_bib33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13104-019-4178-3","article-title":"No detection of EBV, BKV and JCV in breast cancer tissue samples in Iran","volume":"12","author":"Dowran","year":"2019","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.prp.2023.154484_bib34","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1038\/srep02970","article-title":"No association between Epstein-Barr Virus and Mouse Mammary Tumor Virus with breast cancer in Mexican women","volume":"3","author":"Morales-S\u00e1nchez","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2023.154484_bib35","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.prp.2011.09.007","article-title":"Investigation of Epstein-Barr virus in breast carcinomas in Tunisia","volume":"207","author":"Hachana","year":"2011","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.prp.2023.154484_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0304-3835(97)00449-7","article-title":"In situ detection of Epstein\u2013Barr virus in breast cancer","volume":"124","author":"Chu","year":"1998","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2023.154484_bib37","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/ajcp\/103.4.449","article-title":"Absence of Epstein-Barr virus in medullary carcinoma of the breast as demonstrated by immunophenotyping, in situ hybridization and polymerase chain reaction","volume":"103","author":"Lespagnard","year":"1995","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2023.154484_bib38","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<555::AID-IJC10>3.0.CO;2-8","article-title":"Absence of Epstein-Barr virus EBER-1 transcripts in an epidemiologically diverse group of breast cancers","volume":"75","author":"Glaser","year":"1998","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.prp.2023.154484_bib39","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/01.LAB.0000029150.90532.24","article-title":"Lack of Expression of the Epstein-Barr Virus (EBV) gene products, EBERs, EBNA1, LMP1, and LMP2A, in breast cancer cells","volume":"82","author":"Deshpande","year":"2002","journal-title":"Lab Invest"},{"key":"10.1016\/j.prp.2023.154484_bib40","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/jnci\/91.16.1376","article-title":"Detection of Epstein-Barr virus in invasive breast cancers","volume":"91","author":"Bonnet","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.prp.2023.154484_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013603","article-title":"Characterization of Epstein Barr virus latency pattern in argentine breast carcinoma","volume":"5","author":"Lorenzetti","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2023.154484_bib42","first-page":"899","article-title":"Presence of epstein-barr-virus in breast-carcinoma","volume":"6","author":"Luqmani","year":"1995","journal-title":"Int J. Oncol."},{"key":"10.1016\/j.prp.2023.154484_bib43","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.31557\/APJCP.2022.23.7.2351","article-title":"High frequency of epstein-barr virus and absence of papillomavirus in breast cancer patients from Brazilian Northeast","volume":"23","author":"Oliveira","year":"2022","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.prp.2023.154484_bib44","first-page":"59","article-title":"D\u00e9tection du virus d\u2032Epstein-Barr dans les cancers du sein \u00e0 stroma lympho\u00efde","volume":"66","author":"Trabelsi","year":"2008","journal-title":"Ann. De. Biol. Clin."},{"key":"10.1016\/j.prp.2023.154484_bib45","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1054\/bjoc.2000.1672","article-title":"Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas","volume":"84","author":"Fina","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2023.154484_bib46","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s12253-010-9325-z","article-title":"Epstein-Barr virus and breast cancer: lack of evidence for an association in Iranian women","volume":"17","author":"Kadivar","year":"2011","journal-title":"Pathol. Oncol. Res"},{"key":"10.1016\/j.prp.2023.154484_bib47","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0002-9440(10)61728-2","article-title":"No significant association of Epstein-Barr virus infection with invasive breast carcinoma","volume":"159","author":"Chu","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2023.154484_bib48","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/2277-9175.135158","article-title":"Association of Epstein-Barr virus with invasive breast carcinoma and its impact on well-known clinicopathologic parameters in Iranian women","volume":"3","author":"Mohammadizadeh","year":"2014","journal-title":"Adv. Biomed. Res"},{"key":"10.1016\/j.prp.2023.154484_bib49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5507\/bp.2018.014","article-title":"Risks and protective factors for triple negative breast cancer with a focus on micronutrients and infections","volume":"162","author":"Horakova","year":"2018","journal-title":"Biomed. Pap. Med Fac. Univ. Palacky. Olomouc Czech Repub."},{"issue":"Suppl 1","key":"10.1016\/j.prp.2023.154484_bib50","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1007\/s12032-010-9694-x","article-title":"Bcl-2 expression and triple negative profile in breast carcinoma","volume":"28","author":"Kallel-Bayoudh","year":"2011","journal-title":"Med Oncol."},{"key":"10.1016\/j.prp.2023.154484_bib51","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3892\/mco.2014.459","article-title":"Outcome of Epstein-Barr virus-associated primary breast cancer","volume":"3","author":"MAZOUNI","year":"2015","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.prp.2023.154484_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114559","article-title":"Prevalence of papillomaviruses, polyomaviruses, and herpesviruses in triple-negative and inflammatory breast tumors from algeria compared with other types of breast cancer tumors","volume":"9","author":"Corbex","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2023.154484_bib53","doi-asserted-by":"crossref","unstructured":"I. Gupta, M. Ulamec, M. Peric-Balja, S. Ramic, A.-E. Al Moustafa, S. Vranic, H.F. Al-Farsi, Presence of high-risk HPVs, EBV, and MMTV in human triple-negative breast cancer, Hum Vaccin Immunother. 17 (n.d.) 4457\u20134466. https:\/\/doi.org\/10.1080\/21645515.2021.1975452.","DOI":"10.1080\/21645515.2021.1975452"},{"key":"10.1016\/j.prp.2023.154484_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031656","article-title":"Epstein-Barr virus infection and sporadic breast cancer risk: a meta-analysis","volume":"7","author":"Huo","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2023.154484_bib55","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.21873\/invivo.12860","article-title":"Incidence of Epstein-Barr virus among women with breast cancer using monoclonal antibodies for latent membrane protein 1 (LMP1","volume":"36","author":"Salih","year":"2022","journal-title":"Vivo"},{"key":"10.1016\/j.prp.2023.154484_bib56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-9378-6-7","article-title":"Human papillomavirus and Epstein-Barr virus infections in breast cancer from chile","volume":"6","author":"Aguayo","year":"2011","journal-title":"Infect. Agent Cancer"},{"key":"10.1016\/j.prp.2023.154484_bib57","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1309\/LMLIK0VIE3CJK0WD","article-title":"Microarray-based gene expression profiling for molecular classification of breast cancer and identification of new targets for therapy","volume":"41","author":"Sandhu","year":"2010","journal-title":"Lab. Med."},{"key":"10.1016\/j.prp.2023.154484_bib58","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ebiom.2016.05.025","article-title":"Epstein\u2013Barr virus infection of mammary epithelial cells promotes malignant transformation","volume":"9","author":"Hu","year":"2016","journal-title":"EBioMedicine"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382300184X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382300184X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T07:03:49Z","timestamp":1759734229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S034403382300184X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":58,"alternative-id":["S034403382300184X"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154484","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein-Barr virus in breast carcinoma and in triple negative cases impact on clinical outcomes","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154484","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154484"}}